ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Generation of CHD5 Antibodies and Know-out Mouse Model | Children’s Hospital of Philadelphia / Garrett Brodeur | Innovation Grants | 2008 | Pennsylvania |
Trib2 in the Pathogenesis of T-ALL | University of Pennsylvania / Warren Pear, M.D., Ph.D., | Innovation Grants | 2014 | Pennsylvania |
Norepinephrine Transporter-Targeted Pharmacotherapy of Aggressive Neuroblastoma | Children’s Hospital of Philadelphia / Michael Chorny, PhD | Innovation Grants | 2019 | Pennsylvania |
Defining the Cell Surface Landscape of Diagnostic and Relapsed Neuroblastoma: Immunotherapeutic Target Identification | Children’s Hospital of Philadelphia / Sharon Diskin, PhD | Innovation Grants | 2017 | Pennsylvania |
Nanoparticle Delivery of Therapeutic Agents in Neuroblastomas | Children’s Hospital of Philadelphia / Garrett M. Brodeur, MD | Innovation Grants | 2013 | Pennsylvania |
BH3 profiling to define therapy resistance classes in neuroblastoma. | Children’s Hospital of Philadelphia / Michael Hogarty | Innovation Grants | 2009 | Pennsylvania |
Identify Novel Druggable Targets to Treat Philadelphia chromosome-like B-Acute Lymphoblastic Leukemia | Children’s Hospital of Philadelphia / Wei Tong, PhD | Innovation Grants | 2019 | Pennsylvania |
Alternative Splicing in the Pathogenesis of Acute Lymphoblastic Leukemia | Children’s Hospital of Philadelphia / Andrei Thomas-Tikhonenko, PhD | Innovation Grants | 2017 | Pennsylvania |
BH3 Profiling to define therapy resistance classes in neuroblastoma | Children’s Hospital of Philadelphia / Michael Hogarty, MD | Innovation Grants | 2011 | Pennsylvania |
Tumor cell hybridoma vaccine for recurrent neuroblastoma and Ewing sarcoma | The Pennsylvania State University / Ken Lucas, MD | Innovation Grants | 2006 | Pennsylvania |